SCHEMBL8325808

SCHEMBL8325808

Cc1ccc(C(=O)OC[C@@H]2O[C@H](n3cc(F)c(=O)[nH]c3=O)CC2OCc2ccc(Cl)cc2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.44
LMNA P02545 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA12 O43570 3/20 0.40
CA1 P00915 3/20 0.40
CA2 P00918 3/20 0.40
CA5A P35218 3/20 0.40
CA7 P43166 3/20 0.40
CA9 Q16790 3/20 0.40
CA5B Q9Y2D0 3/20 0.40
TYMS P04818 2/20 0.39
TERT O14746 2/20 0.39
TK1 P04183 1/20 0.37
ABCG2 Q9UNQ0 3/20 0.37
ABCB1 P08183 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8325806 1.00 RNASE1 (0.44) RNASE1LMNASMN1; SMN2CA12CA1
SCHEMBL8328405 0.92 RNASE1 (0.47) RNASE1LMNASMN1; SMN2TYMS
SCHEMBL8328409 0.92 RNASE1 (0.47) RNASE1LMNASMN1; SMN2TYMS
SCHEMBL8328151 0.90 TYMS (0.42) RNASE1LMNASMN1; SMN2CA12CA1
SCHEMBL8328147 0.90 TYMS (0.42) RNASE1LMNASMN1; SMN2CA12CA1
SCHEMBL8328242 0.89 LMNA (0.46) RNASE1LMNASMN1; SMN2TYMSTK1
SCHEMBL8328237 0.89 LMNA (0.46) RNASE1LMNASMN1; SMN2TYMSTK1
SCHEMBL8328169 0.84 LMNA (0.58) RNASE1LMNASMN1; SMN2TK1
SCHEMBL8328173 0.84 LMNA (0.58) RNASE1LMNASMN1; SMN2TK1
SCHEMBL8329352 0.83 LMNA (0.45) RNASE1LMNASMN1; SMN2TYMSTK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869464-A HAVING LOW TOXICITY, SUSTAINING LOW CONCENTRATION IN BLOOD FOR EXTENDED PERIOD TAIHO PHARMACEUTICAL CO. LTD. (JP) 1999-02-09 US disclosed
EP-0686641-B1 2'-DEOXY-5-FLUOROURIDINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING THE SAME, AND ANTITUMOR DRUG TAIHO PHARMACEUTICAL CO LTD (JP) 1998-08-26 EP disclosed
EP-0686641-A1 2'-DEOXY-5-FLUOROURIDINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING THE SAME, AND ANTITUMOR DRUG TAIHO PHARMACEUTICAL CO., LTD. (JP) 1995-12-13 EP disclosed